Background
==========

Dendritic cells (DC) play a major role in the innate immune response by directing B lymphocytes and T lymphocytes. We studied the contribution of DC to the immune suppression during thiopentone and midazolam treatment. Previous *in vitro*studies have shown negative effects of thiopentone on immune function \[[@B1],[@B2]\]. Clinical studies suggest that long-term sedation with thiopentone contributes to an increased incidence of nosocomial infections \[[@B3]\]. However, effects of thiopentone on DC have not yet been elaborated.

Materials and methods
=====================

We investigated the effects of clinical doses of thiopentone and midazolam on the differentiation of monocytes to dendritic cells *in vitro*. Monocytes were isolated from buffy coats of healthy donors and cultured in the presence of GM-CSF and IL-4 over 8 days. The cells were incubated with different concentrations of thiopentone and midazolam, respectively. DC were characterized through surface expression of CD1a, CD14, CD16, CD40, CD80, CD83, CD86 and HLA-DR. Cell function was quantified through FITC-dextrane phagocytosis by cytometry.

Results
=======

In contrast to midazolam, high concentrations of thiopentone (50--100 μg/ml) led to notable alteration in the morphology and differentiation of DC. Typical morphologic characteristics like spikes and cell clustering were absent. The surface expression of CD1a was reduced by 83% (± 41%), CD40 by 93% (± 8%) and HLA-DR by 68% (± 35%). Phagocytosis capacity of these cells was decreased by 50% (± 33%).

Conclusion
==========

We conclude that differentiation from monocytes into DC is affected by high concentrations of thiopentone but not by midazolam. This may contribute to an immune suppression during long-term thiopentone sedation.
